IRVINE, California, January 5, 2026 – BioDuro, a leading global contract research, development, and manufacturing Organization (CRDMO), today announced that its Shanghai Free Trade Zone (FTZ) site and Jiangsu site in China have each been awarded a Gold Medal in the 2025 EcoVadis business sustainability assessment for the second consecutive year, while its Beijing site received a Silver Medal. Over the past 12 months, EcoVadis recognized all three sites for outstanding sustainability performance, placing BioDuro consistently within the top 10th percentile of companies evaluated worldwide. These results highlight BioDuro’s commitment to sustainability and ongoing efforts to embed environmental and social responsibility into its business operations.
“These awards reflect the dedication and hard work of our teams,” said Dr. Armin Spura, CEO of BioDuro. “With Shanghai FTZ and Jiangsu sites achieving consecutive Gold Medals and our Beijing site earning Silver this year, and through 30 years of continued innovation since our founding in 1996, we remain committed to applying ESG principles across our operations and throughout our global network of partners and suppliers.”
BioDuro’s global R&D and manufacturing network integrates chemistry, biology, and DMPK capabilities to accelerate programs from preclinical research through commercial manufacturing, supporting a broad range of therapeutic areas while expanding expertise in emerging modalities such as ADCs, peptides, and targeted protein degradation.
About EcoVadis
EcoVadis is a purpose-driven company dedicated to embedding sustainability intelligence into every business decision worldwide. We offer a full range of solutions including IQ-Plus Risk & Compliance Management, EcoVadis Ratings, and Carbon Action Module for Scope 3 Decarbonization. Key features like 360/Live News Monitoring, Academy E-learning and Corrective action plans help companies comply with ESG regulations, reduce GHG emissions, and improve the sustainability performance of their business and value chain across 250 industries in 185 countries.
About BioDuro
BioDuro, an Advent portfolio company, is a CRDMO with a 30-year proven track record. Headquartered in Irvine, California, USA, our global presence spans seven sites across the United States and China, with over 2,000 employees. Specializing in both small and large molecule discovery, development, scale-up, and manufacturing, we offer fully integrated services from early drug discovery to commercial manufacturing across chemistry, biology, drug metabolism and pharmacokinetics (DMPK), drug substance, and drug product. For more information, please visit http://www.bioduro.com/
Media Enquiries
Christina Coby, Associate Director, Marketing, BioDuro
Email: christina.coby@bioduro.com
Mobile: +1 (619) 414 7409
Chris Halling
Orientation Marketing
Email: chris.halling@orientation.agency
Mobile: +44 (0)7580 041073
Home
